These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 17180161)

  • 1. HIV and antiretroviral therapy in the brain: neuronal injury and repair.
    Ellis R; Langford D; Masliah E
    Nat Rev Neurosci; 2007 Jan; 8(1):33-44. PubMed ID: 17180161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
    Stephens JR; Rathbun RC; Lockhart SM; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Nov; 100(11):417-24. PubMed ID: 18183858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of HIV.
    Hult B; Chana G; Masliah E; Everall I
    Int Rev Psychiatry; 2008 Feb; 20(1):3-13. PubMed ID: 18240058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral agents used in the treatment of HIV infections.
    Harris W; Brown G
    ABNF J; 2001; 12(3):67-9. PubMed ID: 11760502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New challenges in therapeutic management of human immunodeficiency virus-infected children].
    Faye A
    Arch Pediatr; 2007 Feb; 14(2):212-8. PubMed ID: 17222540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
    Mannheimer SB; Wold N; Gardner EM; Telzak EE; Huppler Hullsiek K; Chesney M; Wu AW; MacArthur RD; Matts J; Friedland G;
    Clin Infect Dis; 2008 Mar; 46(6):941-5. PubMed ID: 18279044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection of the central nervous system: clinical features and neuropathogenesis.
    Boissé L; Gill MJ; Power C
    Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus and the central nervous system.
    Mirza A; Rathore MH
    Semin Pediatr Neurol; 2012 Sep; 19(3):119-23. PubMed ID: 22889541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated nephropathy in the era of antiretroviral therapy.
    Wyatt CM; Klotman PE
    Am J Med; 2007 Jun; 120(6):488-92. PubMed ID: 17524746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
    Klibanov OM; Clark-Vetri R
    Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.
    Sosnik A; Chiappetta DA; Carcaboso AM
    J Control Release; 2009 Aug; 138(1):2-15. PubMed ID: 19445981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term suppression of HIV infection: benefits and limitations of current treatment options.
    Sension MG
    J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S2-10. PubMed ID: 17275719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV agents. Overcoming barriers to a cure.
    TreatmentUpdate; 2005; 17(6):2-4. PubMed ID: 17228474
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
    Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
    Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant.
    Feiterna-Sperling C; Hüseman D; Timme J; Bührer C; Obladen M
    Pediatr Infect Dis J; 2008 Jun; 27(6):564-7. PubMed ID: 18449067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.